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Chiral drugsThe enantiomeric and diastereomeric proﬁling of chiral pharmaceuticals (ephedrine, norephedrine, atenolol and
venlafaxine) and illicit drugs (amphetamine,methamphetamine, 3,4-methylenedioxyamphetamine (MDA), 3,4-
methylenedioxy-N-methylamphetamine (MDMA) and 3,4-methylenedioxy-N-ethylamphetamine (MDEA))was
undertaken over a period of fourteen consecutive days in threewastewater treatment plants (WWTPs) in the city
of Valencia, Spain. Degradation efﬁciency of WWTPs was found to be compound and enantiomer dependent.
Selective enantiomer enrichment was observed for several target analytes. Amphetamine and MDMA were
enriched with R(−)-enantiomers. 1S,2S(+)-pseudoephedrine was found to be more readily degradable during
activated sludge treatment than its diastereomer 1R,2S(−)-ephedrine. Atenolol underwent enrichment with
either S(−)- or R(+)-enantiomer in different WWTPs. This unexpected enantiomeric variation in the
stereoselective degradation of atenolol could be attributed to different processes utilized during activated sludge
treatment. The application of (enantiomeric) proﬁling of wastewater revealed usage patterns of chiral drugs in
the Valencia region.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
More than 50% of pharmaceuticals and illicit drugs currently in use
are chiral (Lien et al., 2006). Although they are usually manufactured
as racemic compounds, they can be stereoselectively degraded in
humans (for example as a result of stereoselective metabolism) and/
or during wastewater treatment as a result of microbial processes.
Since activity and toxicity of these compounds are often isomer-
dependent (Kasprzyk-Hordern, 2010), it is of importance to understand
the inﬂuence of wastewater treatment processes in the selective degra-
dation of chiral drugs in order to improve the performance ofwastewater
treatment plants (WWTPs) and to protect the receiving aquatic
environment. Fluoxetine, for example, is one of the most toxic human44 1225 386231.
asprzyk-Hordern).
. This is an open access article underpharmaceuticals reported so far. Its ecotoxicity is currently assessed
for the racemate (Kasprzyk-Hordern, 2010). However, recent research
indicates that toxic effects of ﬂuoxetine are enantiomer dependent:
S(+)-ﬂuoxetine is 9.4 times more toxic to Pimephales promelas than
R(−)-ﬂuoxetine (Stanley et al., 2007). Speciﬁc inter-species toxic
effects also exist among enantiomers; for example, S(−)-propranolol
has a higher chronic toxicity to Fathead Minnows than its enantiomer,
but the opposite is true in Daphnia magna (Nikolai et al., 2006).
There is a lack of information on the stereoselective and/or stereo-
speciﬁc fate and effects of chiral pharmaceuticals and illicit drugs in
the environment. Although chiral HPLCmethods have been extensively
used for stereoisomer separation of drugs in pharmaceutical prepara-
tions they are usually not directly amenable to the analysis of chiral
drugs in complex environmental matrices and at trace concentrations
(Evans and Kasprzyk-Hordern, 2014). Recently, new HPLC methods
using chiral columns packed with antibiotics or proteins coupled withthe CC BY license (http://creativecommons.org/licenses/by/3.0/).
Table 1
Operational parameters of studied WWTPs.
Characteristics Pinedo-I Pinedo-II Quart-Benager
Coordinates UTM X:728552 X:728371 X:722456
(ETRS 89 zone 30N) Y: 4368031 Y: 4368153 Y: 4370419
Z: 5 Z: 5 Z: 22
Population served (thousands) 351,198 942,774 166,942
Flows (m3/day) 100,602 242,580 35,903
Wastewater (% industrial/%
domestic)
0/100 0/100 60/40
Treatment AS AS/N removal AS/P removal
Average daily sewage ﬂow (m3/d) 106,537 236,396 37,998
Designed treatment capacity (m3/d) 124,800 200,000 60,000
Inﬂuent BOD (mg/L)a 248.2 263.7 318.1
AS: Activated Sludge; N: Nitrogen; P: phosphorus; BOD: Biological Oxygen Demand.
a Annual average.
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ysis of several chiral drugs in WWTPs and/or surface waters (Bagnall
et al., 2012; Kasprzyk-Hordern and Baker, 2012b; MacLeod and Wong,
2010; Nikolai et al., 2006). Among these chiral drugs are: atenolol,
metoprolol, ﬂuoxetine, venlafaxine, ibuprofen, ketoprofen, naproxen,
amphetamine, methamphetamine and ephedrine (MacLeod and Wong,
2010; Nikolai et al., 2006; Barclay et al., 2012; Hashim and Khan, 2011;
Fono and Sedlak, 2005; Buser et al., 1999; López-Serna et al., 2013;
Kasprzyk-Hordern and Baker., 2012b).
This paper presents for the ﬁrst time the results of a twoweek study
of threeWWTPs in Valencia City and surroundings aiming at estimating
the occurrence and stereoselective fate of ﬁve chiral pharmaceuticals:
(ephedrine, pseudoephedrine, norephedrine, atenolol and venlafaxine)
and ﬁve illicit drugs (amphetamine, methamphetamine, 3,4-methyl-
enedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine
(MDMA) and 3,4-methylenedioxyethamphetamine (MDEA)).2. Materials and methods
2.1. Sampling
In a sampling campaign of two weeks (April 17–May 1 of 2012),
inﬂuent and efﬂuent 24 h-composite samples (time-proportional
mode) were collected in three WWTPs serving the city of Valencia
(Spain) and the surrounding towns: Pinedo-I, Pinedo-II and Quart-
Benager (Fig. 1). TheseWWTPs have tertiary treatments but they differ
in the type of technology utilized for secondary treatment: Pinedo-I
utilizes only activated sludge, Pinedo-II utilizes activated sludge and
phosphorus removal, and Quart-Benager utilizes activated sludge and
nitrogen removal (see operational details of studied WWTPs in
Table 1). Pinedo-I treats only wastewaters of the city of Valencia.
Pinedo-II is the biggest and serves Valencia and surrounding towns. It
has a very complete primary treatment and a secondary treatment,
digestion and dehydration of sludge (200,000m3/day). This installation
is complemented by a treatment with Densadeg, ﬁlters, sand and UV
disinfection with a capacity of 350,000 m3/day (100,000 m3/day forFig. 1. Sampling locatregeneration of the ecological ﬂow of Natural Park) and 250,000 m3/day
for irrigation. Quart-Benager serves the towns of the industrial belt of
Valencia.
24 h-composite samples were taken in 2 L plastic bottles (poly-
ethylene) with Teﬂon protected caps and were transported to the
laboratory for their immediate analysis. If this was not possible, the
samples were frozen at−20 °C until analysis to prevent degradation
of the target residues.2.2. Chemicals
All reference standards (±)-amphetamine (AMP), (±)-metham-
phetamine (MAMP), (±)-MDA, (±)-MDMA, (±)-MDEA, (−)-ephed-
rine (EPH), (+)-pseudoephedrine (PEPH), (±)-norephedrine (NOR),
(±)-atenolol (ATE), and (±)-venlafaxine (VEN) were purchased from
LGC Standards (Teddington, UK) and Sigma-Aldrich (Gillingham, UK).
The surrogate standard (SS) (±)-MDA-d5 was added to the samples
before solid-phase extraction (SPE). Internal standards (IS): (±)-meth-
amphetamine-d5, (±)-MDMA-d5, (±)-MDEA-d5 and (±)-atenolol-d7ions in Valencia.
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glassware was silanized with dimethylchlorosilane (5% DMDCS in
toluene) to minimize sample loss through adsorption of basic analytes
onto OH-sites present on glass surface.
2.3. Analytical methodology
Once in the laboratory, and after the addition of SS, all samples were
ﬁltered through a 0.45 μm glass microﬁber ﬁlter and subsequently
extracted following a protocol described elsewhere (Kasprzyk-
Hordern et al., 2010). Brieﬂy, 50 mL of water was extracted using an
HLB cartridge. The cartridge was then rinsed with Milli-Q water, dried
under vacuum for 15 min, frozen and then eluted prior to the analysis
with 6 mL of methanol. The eluent was evaporated to dryness and
reconstituted in 500 μL of methanol/water (25:75, v/v). 5 μL of IS at
10 ng/μL was added to each sample. Vials were stored at−18 °C until
analysis. For each sample, three extractionswere carried out and subse-
quently analyzed.
Waters ACQUITY UPLC™ system (Waters, Manchester, UK)
consisting of ACQUITY UPLC™ binary solvent manager and ACQUITY
UPLC™ sample manager was used for the separation of analytes.
Chiral-CBH column, 100 × 2 mm, 5 μm (Chromtech, Congleton, UK)
was used for the separation of enantiomers of chiral pharmaceuticals
and illicit drugs. The separation of chiral drugs was carried out in
isocratic conditions with a mobile phase (pH, 5.0) composed of 90%
H2O, 10% 2-propanol and 1 mM ammonium acetate. Injection volume
was 20 μL. The column was kept at 25 °C and the temperature in the
sample manager was kept at 4 °C. The ﬂow rate of mobile phase was
0.075 mL/min, which allowed for the introduction of mobile phase
from LC into MS without splitting.
A XevoTQD (triple quadrupole) mass spectrometer (Waters,
Manchester, UK) equipped with an electrospray ionization source was
used for enantiomeric proﬁling. The analyses were analyzed in positive
ionmodewith a capillary voltage of 3 kV, a source temperature of 150 °C
and a desolvation temperature of 200 °C. A cone gas ﬂow of 0 L/h and
desolvation gas ﬂow of 450 L/h were used. Nitrogen, used as a nebuliz-
ing and desolvation gas, was provided by a high purity nitrogen gener-
ator (Peak Scientiﬁc Instruments Ltd, UK). Argon (99.999%)was used as
a collision gas. MassLynx 4.1 (Waters, UK) software was used to collect
and analyze the obtained data. Mass spectrometry analyses were per-
formed in the selected reaction monitoring (SRM) mode, measuring
the fragmentation of the protonated pseudo-molecular ions of each
chiral drug (Table S1, Supplementary material). A dwell time of
200ms per ion pair was used tomaintain high sensitivity of the analysis
and required a number of data points across the chromatographic peak.
All instrumental and method validation parameters such as: linearity
and range, accuracy, precision, detection and quantiﬁcation limits and
calibration curve were determined (Table S2, Supplementary material).
A detailed discussion of this method is presented elsewhere (Kasprzyk-
Hordern and Baker, 2012a,b; Kasprzyk-Hordern et al., 2010; Bagnall
et al., 2012).
The relative concentration of enantiomers of chiral drugs was
expressed as the enantiomeric fraction (EF) and was calculated using
the following equation:
EF ¼ þð Þþð Þ þ −ð Þ
where (+) and (−) are concentrations for (+) and (−)-enantiomers.
In the case of amphetamine, methamphetamine, MDMA, MDA and
MDEA, enantiomers were identiﬁed as R(−)- and S(+)-enantiomers.
In the case of atenolol and venlafaxine, they were identiﬁed as
R(+)- and S(−)-enantiomers.
Ephedrine/pseudoephedrine has two chiral centers and as a result
two pairs of enantiomers. The ephedrine enantiomers have a diastereo-
meric relationship with pseudoephedrine enantiomers. Therefore, for1R,2S(−)-ephedrine and 1S,2S(+)- pseudoephedrine diastereomeric
fraction (DF) was also calculated:
DF ¼ 1S;2S þð Þ−pseudoephedrine
1R;2S −ð Þephedrineþ 1S;2S þð Þpseudoephedrine :
Removal efﬁciency for each compound and WWTP were calculated
from mean concentrations of analytes measured in WWTP efﬂuent
and inﬂuent samples using the following equation:
%Removal Efficiency ¼ 1− Effluent½ 
Inffluent½ 
 
 100:
100% elimination was assumed when the analyte was detected in
the inﬂuent water but not in the efﬂuent.
2.4. Estimation of drug usage at the community level in main urban areas
of Valencia
Drug usage in the city of Valencia and adjacent residential areas was
calculated fromdrug concentrationsmeasured at the inlets of the inves-
tigated WWTPs. The stability of compounds in raw wastewater and
sorption to suspended particle matter was taken into account as sug-
gested by Baker et al. (2012, 2014). The consumption was calculated
with the usage of the following formula:
Q mg  day−1  1000people−1
 
¼
Qday  1000
 
 100
Uex
 
Mratio
Ninh
1000
where Qday is the load of the DTR, Uex is the percentage of the DTR
urinary excretion, Mratio is the parent drug/DTR molar ratio and Ninh is
the number of inhabitants linked to the WWTPs estimated assuming
an organic per-capita load of 60 g BOD5 Hab−1 day−1 (Andreottola
et al., 1994). DTR percentages of excretion were obtained from Postigo
et al. (2011) for AMP, MAMP, MDMA and ephedrine, and from Lai
et al. (2011) for atenolol and venlafaxine.
Qday was calculated using the following equation:
Qday gday
−1
 
¼
Conc  −Sta
100−Staþ 1
  
þ Sorp
 
 Flow
1  109
where Conc corresponds to the drug target residue (DTR) concentration
in wastewater (ng L−1), Sorp is the DTR concentration sorbed to
suspended particulate matter (ng L−1), Flow is the wastewater inﬂuent
volume over a 24 hour period (m3 day−1) and Sta is the stability change
of each compound (%) after 12 h (see Baker et al., 2012 for stability
data). In the case of atenolol sorption to SPM and stability factors were
not available. Therefore, these parameterswere not used in load calcula-
tions. For the list of parameters used in above calculations see Table S3.
3. Results and discussion
Daily loads of the investigated pharmaceuticals and drugs of abuse in
analyzed inﬂuent wastewater samples are presented in Figs. 2, 3 and 4
for Pinedo-I, Pinedo-II and Quart-Benager WWTPs respectively.
3.1. Occurrence of chiral drugs in wastewaters of Valencia
MDA, MDEA and norephedrine were not detected in any analyzed
wastewater samples. Amphetamine, methamphetamine and MDMA
were present at trace ppt levels. On the other hand, atenolol and
venlafaxine were quantiﬁed at the highest concentrations reaching
1322 ng/L for R(+)-atenolol and 390 ng/L for R/S(±)-venlafaxine,
both in Pinedo-II WWTP. A detailed list of concentrations of chiral
050
100
150
200
250
300
350
400
Tu
es
da
y
W
ed
ne
sd
ay
Th
ur
sd
ay
Fr
id
ay
Sa
tu
rd
ay
Su
nd
ay
M
on
da
y
Tu
es
da
y
W
ed
ne
sd
ay
Th
ur
sd
ay
Fr
id
ay
Sa
tu
rd
ay
Su
nd
ay
M
on
da
y
Tu
es
da
y
Lo
ad
s 
(g
/da
y)
1S,2S(+)-pseudoephedrine
1R,2S(-)-ephedrine
R/S(±)-venlafaxine
S(-)-atenolol
R(+)-atenolol
0
2
4
6
8
10
12
Tu
es
da
y
W
ed
ne
sd
ay
Th
ur
sd
ay
Fr
id
ay
Sa
tu
rd
ay
Su
nd
ay
M
on
da
y
Tu
es
da
y
W
ed
ne
sd
ay
Th
ur
sd
ay
Fr
id
ay
Sa
tu
rd
ay
Su
nd
ay
M
on
da
y
Tu
es
da
y
Lo
ad
s 
(g
/da
y)
S(+)-MDMA
R(-)-MDMA
R/S(±)-methampetamine
S(+)-amphetamine
R(-)-amphetamine
Fig. 2. Loads (g/day) of chiral drugs in inﬂuent waters from Pinedo-I WWTP.
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expected, Pinedo-II with 100% communal inputs was characterized by
the highest concentrations of chiral drugs and Quart-Benager WWTP
with 60% industrial contribution to wastewater by the lowest. Illegal
drugs were not detected in any of the samples collected in this WWTP
probably due to high dilution of domestic wastewater with industrial
efﬂuent.
Furthermore, as can be seen from Figs. 2 and 3 (representing data
from Pinedo-I and Pinedo-II WWTPs) loads of illicit drugs increased
during weekend days. Such an effect was not observed in the case of
prescription medications: atenolol and venlafaxine. These temporal
changes in daily illicit drug loads are attributed to their increased use
during weekends (e.g. MDMA) and are a phenomenon which has
recently been widely reported (Huerta-Fontela et al., 2007; Van Nuijs
Alexander et al., 2009; Pedrouzo et al., 2011).
3.2. Enantiomeric proﬁling of wastewaters
Enantiomers of venlafaxine and methamphetamine were not fully
separated in the chromatographic column probably because of matrix
components interfering with the separation process. Thus, their enan-
tiomeric fraction could not be calculated. Enantiomeric fractions and
diastereomeric fractions of other chiral drugs studied are shown in
Fig. 5.
With the exception of a few cases, there was nearly no inter-day
variation observed in the value of EF for the target drugs quantiﬁed in
wastewater. In contrast, signiﬁcant temporal (months and seasons)
variations in enantiomeric fractions were reported by other authors
(Kasprzyk-Hordern and Baker, 2012b; MacLeod and Wong, 2010;Nikolai et al., 2006). Physicochemical properties of water including tem-
perature, pH, oxygen, nitrogen and phosphorus concentration, etc. have
direct inﬂuence on the behavior of microorganisms during wastewater
treatment and may have a decisive inﬂuence regarding the EF values
(Gasser et al., 2012). Since these parameters are practically constant
during the two week sampling campaign, no high inter-day variations
in EFswere expected.
MDMA is illegally synthesized as racemate. However, humans
metabolize mainly S(+)-MDMA, which leads to the enrichment of
MDMA with R(−)-enantiomer (EF b 0.5). Therefore MDMA, if
consumed, is likely to be present in wastewater enriched with
R(−)-enantiomer. Such a situation was observed in both Pinedo-I
and Pinedo-II WWTPs. Amphetamine is usually produced as racemate
and similarly to MDMA, S(+)-amphetamine metabolizes faster than
R(−)-enantiomer if administered in a racemic form (Kasprzyk-
Hordern andBaker, 2012b). Indeed, EFs of amphetaminewere quantiﬁed
to be 0.42 and 0.38 in Pinedo-I andPinedo-IIWWTPs respectively. Unfor-
tunately, MDMA and amphetamine were practically not detected in
efﬂuents, so the enantioselective fate of these compounds in the
WWTPs studied could not be veriﬁed.
Atenolol belongs to the group of beta-blockers and is marketed as
racemate. Pharmacological action of beta-blockers in humans is
stereoselective: S(−)-enantiomers usually reveal much higher cardiac
beta-blocking potency than R(+)-enantiomers. On the other hand
R(+)-enantiomers have higher activity in blocking β2 receptors in
ciliary processes (Kasprzyk-Hordern, 2010). Modest stereoselectivity
in renal clearance of atenolol in humans in favor of S(−)-enantiomer re-
sults in the enrichment of excreted atenolol with this enantiomer
(Mehvar and Brooks, 2001). Indeed, in this study, atenolol was found
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Fig. 3. Loads (g/day) of chiral drugs in inﬂuent waters from Pinedo-II WWTP.
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ally, further enrichment of atenolol with R(+)- or S(−)-enantiomer
was observed during wastewater treatment and depended on the
WWTP technology utilized. In Pinedo-II WWTP, atenolol was enriched
with S(−)-enantiomer, while in Pinedo-I and Quart-Benager WWTPs
atenolol was enriched with R(+)-enantiomer. Enrichment of atenolol
with R(+)-enantiomer has been previously reported by Kasprzyk-
Hordern and Baker (2012a,b). On the other hand, Nikolai et al. (2006),
MacLeod and Wong (2010) and López-Serna et al. (2013) reported the
enrichment of atenolol with S(−)-enantiomer. Although, in this work,0
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Fig. 4. Loads (g/day) of chiral drugs in inﬂueall studied WWTPs utilize activated sludge treatments, Pinedo-II also
has biological nitrogen removal. During this process, inﬂuent waters un-
dergo nitriﬁcation with different bacteria in aerobic conditions. These
bacteriamight favor degradation of R(+)-atenolol, leading to the enrich-
ment of atenolol with S(−)-enantiomer. It is worth mentioning that
nitriﬁcation process is highly favored at higher temperatures of
wastewaters (Antoniou et al., 1990). Such a situation was observed in
Pinedo-II where recorded temperatures varied from 18.4 to 20.3 °C.
More pronounced enrichment of atenolol with S(−)-enantiomer has
also been observed in summer season in two CanadianWWTPs utilizingSa
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54 P. Vazquez-Roig et al. / Science of the Total Environment 494–495 (2014) 49–57activated sludge and nitrogen removal: Capital Region (MacLeod and
Wong, 2010) and Edmonton Gold Bar (Nikolai et al., 2006). Further
studies have to be carried out to verify mechanisms underlying differ-
ential degradation patterns of enantiomers of atenolol.
Ephedrine and pseudoephedrine have two chiral centers and as a
result exist in the form of two pairs of enantiomers. Only two isomers
are natural: 1R,2S(−)-ephedrine and 1S,2S(+)-pseudoephedrine.
Both isomers are marketed in pure isomeric forms. It is interesting to
note that both 1R,2S(−)-ephedrine and 1S,2S(+)-pseudoephedrine
were present in raw wastewater at similar concentration levels. Fur-
thermore, the enrichment of ephedrines with 1R,2S(−)-ephedrine
was observed in WWTP Pinedo I and Quart-Benager. This is of signiﬁ-
cant ecotoxicological importance as 1R,2S(−)-ephedrine is known to
be more potent than 1S,2S(+)-pseudoephedrine. Further work is
being undertaken to verify ecotoxicity of ephedrine isomers. It is impor-
tant to note that no stereoselectivity was observed in WWTP Pinedo II.
Such an outcome concurs with results presented by Kasprzyk-Hordern
and Baker (2012a,b).
3.3. Removal of chiral drugs during wastewater treatment
The average elimination rates of chiral drugs in the studied WWTPs
ranged from−29 to 100% (see Fig. 6). Degradation efﬁciency ofWWTPs-60
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Fig. 6.Median removal rates (%) of studied chwas compound and enantiomer dependent. Amphetamines and ephed-
rineswere highly degraded in all three studiedWWTPs. Due to both low
concentration levels in wastewater inﬂuent and high removal during
treatment, amphetamine and methamphetamine were not detected
in efﬂuent samples. Stereoselective degradation was observed in
the case of MDMA as S(+)-MDMA was more readily degraded than
R(−)-MDMA. Similarly, 1S,2S(+)-pseudoephedrine was more read-
ily degraded than its diastereomer 1R,2S(−)-ephedrine in Pinedo-I
and Quart-Benager WWTPs. However, in Pinedo II similar degradation
of two studied diastereomers was observed.
Atenolol was found to be poorly removed with efﬁciencies differing
between studied WWTPs (see Fig. 6). The removal efﬁciency of
S(−)-atenolol was higher than R(+)-enantiomer, with the excep-
tion of Pinedo-II WWTP. A similar situation was observed in the case
of MDMA. Additional research is, however, needed to fully understand
and explain the differences observed. Venlafaxine was poorly degraded
in Pinedo-I WWTP (18%), but in Pinedo-II and Quart-Benager its con-
centration increased after treatment. This low degradation has been
also reported by other authors (Kasprzyk-Hordern and Baker, 2012a,
b). Probable explanation could be the cleavage of free venlafaxine
from their glucuronide conjugated forms due to fecal bacterial enzymes,
the back-reversion of its main metabolite O-desmethylvenlafaxine into
its original form, hydrolysis, and desorption from particulate matterR
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is suggested that different strains of bacteria present during N and P
removal in Pinedo-II and Quart-Benager WWTPs could favor degrada-
tion of venlafaxine conjugates and transformation of its metabolite.
3.4. Drug usage at the community level in the main urban areas of Valencia
Fig. 7 shows drug consumption estimates for each drug and two
WWTPs investigated: Pinedo I and II. None of the illicit drugs was
detected in Quart-Benager WWTP. This is probably due to high contri-
bution of industrial wastewater (up to 60%) in analyzed wastewater in-
ﬂuent. Such high contribution from industry to wastewater collected in
Quart-Benager made back-calculation of drug usage estimates in this
particular WWTP impossible. Therefore, below discussion concerns
Pinedo I and II only.
As expected, usage of prescription drugs was found to be much
higher than usage of illicit drugs. Venlafaxine consumptionwas estimat-
ed in the range of 10–33 g/day/1000 inh, which is much higher than es-
timates reported by Baker et al. (2014) and Lai et al. (2011). The
excretion of venlafaxine in the urine accounts for only 4.7% of the intake
dose as venlafaxine is excreted mainly as O-demethyl-venlafaxine
(Howell et al., 1993). Low excretion rates of venlafaxine and using par-
ent compound rather than itsmetabolite (and therefore also accounting
for direct disposal of unused drug) could result in overestimation of the
population consumption (Boleda et al., 2009). Therefore, it is inappro-
priate to monitor concentrations of venlafaxine for consumption esti-
mation. Indeed, Baker at al. (2014) reported signiﬁcant overestimation
of consumption estimates for venlafaxine using wastewater analysis
(1276 mg/day/1000 inh) when compared to the UK National Health
Service prescription cost analysis data (417 mg/day/1000 inh). Results
for venlafaxine presented in Fig. 7 should be therefore considered on a
semi-quantitative basis. A more appropriate DTR is likely to be the
main metabolite O-desmethylvenlafaxine (Baker et al., 2014).
Daily estimates of atenolol use revealed a constant pattern of
atenolol usage throughout the two week sampling campaign (0.7–
2.2 g/day/1000 inh). Two week average usage of atenolol was estimat-
ed to be 1 g/day/1000 inh in Pinedo I WWTP. On the other hand, aten-
olol use based on analysis of Pinedo II wastewater was higher and
denoted 1.3 g/day/1000 inh. This indicates that population served by
Pinedo II either consumed higher quantities of atenolol (which is un-
likely) or disposed unused atenolol to the sewerage system. Indeed,
slight enrichment of atenololwith S(−)-enantiomer in Pinedo I inﬂuent
indicated that large proportion of atenolol residue present in analyzed
wastewater could be associated with consumption of atenolol rather
than direct disposal of unused drug. This is because, as discussed in
Section 3.2, atenolol after consumption by humans is excreted in the
urine enriched with S(−)-enantiomer. In contrast, atenolol quantiﬁed
in Pinedo II was racemic. This indicates that large proportion of atenolol
might have originated from direct disposal of unused atenolol or other
sources. However, futureworkwill have to be undertaken to investigate
this phenomenon and to fully understand sources of atenolol loads in
wastewater. However, it is worth emphasizing that according to
Spanish Agency of Medicines and Sanitary Products, consumption of
atenolol has been steadily increasing over recent years andwas estimat-
ed at 7.63 doses/1000 inh/day in 2006 (Spanish Agency of Medicines
and Sanitary Products, 2006). Assuming 100 mg of atenolol per one
daily dose, 7.63 doses equal 0.763 g/day/1000 inh, which agrees with
our estimates. This suggests that wastewater analysis could be used to
estimate drug use in studied communities. Chiral analysis provides yet
another dimension to wastewater based estimates of drug use as it
allows for tracking of origin of drug residue in wastewater and as a re-
sult, it helps with making a distinction between direct disposal of
drugs (thosewith enantioselectivemetabolism) and their consumption.
Data presented in Fig. 7 revealed an irregular pattern of amphet-
amine use. The highest levels corresponded to Friday (8.7 mg/day/
1000 inh) and Saturday (9.6 mg/day/1000 inh) during the secondweekend of sampling in Pinedo-II, while in Pinedo-I the highest levels
were recorded for Monday (13.0 mg/day/1000 inh) and Tuesday
(13.3 mg/day/1000 inh). Zuccato et al. (2008) also reported similar
patterns. Amphetamine residues in wastewater may be also a result of
metabolism of other amphetamine-type drugs, such as methamphet-
amine, phenproporex and phenetylline (Postigo et al., 2011), and thus
being their higher consumption not limited to weekend periods. This
however seemsnot to be the case in this study as enantiomeric fractions
are constant at 0.42 ± 0.01 and 0.38 ± 0.01 (amphetamine enriched
with R(−)-enantiomer) in the case of Pinedo-I and -II respectively, indi-
cating consumption of racemic amphetamine (Kasprzyk-Hordern and
Baker, 2012a). Consumption of this drug in Valencia is similar to other
European cities (Thomas et al., 2012; Ort et al, 2014) and clearly
below amphetamine estimates reported in Antwerp (Belgium) and
the main cities of The Netherlands.
Methamphetamine data showed increased (although irregular) use
during weekend in Pinedo-II, while in Pinedo-I a random distribution
was observed (Fig. 7). Usage of this drug in the Valencia region is slight-
ly above the European average, with the exception of some cities of
Finland, Norway and Czech Republic (Thomas et al., 2012), which
presented loads of methamphetamine reaching 350 mg/day/
1000 inhabitants.
MDMA data, similarly to methamphetamine data, revealed a clear
weekly pattern of increased use during weekend in Pinedo-I and -II
WWTPs (Fig. 7). Furthermore, its use was found to be high in the
Valencia region when compared to many European cities (Thomas
et al., 2012). Usage of MDMA ranged from 7 mg/day/1000 inhabitants
to 49 mg/day/1000 inhabitants throughout the two week sampling
campaign. It was only exceeded by Antwerp (Belgium), London (UK),
Amsterdam, Eindhoven and Utrecht (The Netherlands). Furthermore,
enantiomeric fractions of MDMA were found to be consistent
throughout the two week sampling campaign and denoted 0.22 ±
0.01 and 0.28 ± 0.02 (MDMA enriched with R(−)-enantiomer) in the
case of Pinedo-I and -II respectively. This indicates that MDMA residue
quantiﬁed in wastewater was due to consumption and not direct dis-
posal of unused drug. Kasprzyk-Hordern and Baker (2012a) drew simi-
lar conclusions. Interestingly, Emke et al. (2013) reported racemic
MDMA in a study of aWWTP in Ultrecht, which indicated the direct dis-
posal of unused MDMA possibly as a result of a police raid at a nearby
illegal production facility.4. Conclusions
Twoweeksmonitoring of threeWWTPs in the region of Valencia re-
vealed that, as expected, atenolol, (pseudo)ephedrine and venlafaxine
were present in wastewater at the highest concentrations. On the
other hand, MDA, MDEA and norephedrine were not detected in any
of the analyzed samples. Except for ephedrine, drugs of abuse were
quantiﬁed in inﬂuent wastewater at very low levels, being practically
not detected in efﬂuent samples. The elimination patterns of the target
compounds depended on WWTP and the studied substance. Drugs of
abuse were highly degraded in all three WWTPs, while atenolol was
poorly removed. Venlafaxine, depending on technology utilized, was
either poorly removed or formed because of cleavage of venlafaxine
conjugates, back-reversion of metabolites or unexpected processed
taking place during treatment.
Throughout the two week sampling campaign, there was nearly no
inter-day variation in the value of EF for any particular drug in all
three WWTPs studied. However, enantiomeric enrichment was com-
pound and wastewater treatment plant dependent. Remarkably, de-
pending on wastewater treatment technology utilized, the enrichment
of atenolol with either R(+)- or S(−)-enantiomer was observed. This
unexpected enantiomeric variation in the stereoselective degradation
of atenolol could be attributed to different processes utilized during ac-
tivated sludge treatment. Additional studies on the effect of WWTP
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undertaken to explain these phenomena.
The application ofwastewater enantiomeric proﬁling revealedusage
patterns of chiral drugs in the Valencia region. Usage of amphetamine
showed an irregular pattern throughout the two week sampling cam-
paign, while methamphetamine in Pinedo-IIWWTP showed a slight in-
crease (although still irregular) in daily loads throughout the weekend.
However, such an effect was not observed in Pinedo-I WWTP. MDMA
showed a clear weekly pattern of increased daily loads duringweekend,
in both Pinedo-I and -IIWWTPs. In summary, Valencia showed a level of
consumption above many European cities, but below levels observed in
many large cities of The Netherlands, Finland and Belgium.
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